H 2447
An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill would allow doctors in Massachusetts to prescribe a 90-day supply of testosterone therapy medications for patients who meet certain medical criteria. The goal is to improve access to these medications and reduce the frequency of prescriptions. It aims to streamline the process for individuals requiring long-term testosterone treatment.
Key provisions
- Allows for a 90-day prescription of testosterone therapy medications.
- Applies to medically necessary cases of testosterone therapy.
- Referenced to the House Committee on Public Health and then the House Committee on Health Care Financing.
- Currently under review by the House Ways and Means Committee.
Who is affected
- Individuals requiring testosterone therapy medication.
- Healthcare providers prescribing testosterone therapy.
- The Massachusetts healthcare system.
Notable changes
- Currently, many prescriptions are for a 30-day supply, requiring frequent refills.
- This bill would potentially reduce the administrative burden for patients and providers.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Natalie M. Higgins
Cosponsors
James B. Eldridge
Lindsay N. Sabadosa
Natalie M. Higgins
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.2447 194th (Current)
An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
By Representative Higgins of Leominster, a petition (accompanied by bill, House, No. 2447) of Natalie M. Higgins, Lindsay N. Sabadosa and James B. Eldridge relative to prescriptions for testosterone therapy medications. Public Health.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Natalie M. Higgins Status: Referred to House Committee on Ways and Means
Tabs
Bill History Petitioners Committee Vote Fiscal Note Committee Summary
Bill History
Displaying 8 actions for Bill H.2447
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Public Health |
| 2/27/2025 | Senate | Senate concurred |
| 6/6/2025 | Joint | Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1 |
| 9/11/2025 | House | Reporting date extended to Thursday, October 9, 2025 |
| 10/16/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
| 4/15/2026 | House | Committee recommended bill ought to pass and referred to the committee on House Ways and Means |
Similar Bills
H.2316 192nd (2021 - 2022)
An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
H.2194 193rd (2023 - 2024)
An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
H.4112 194th (Current)
An Act relative to firefighting water supplies and a state cistern program
H.976 194th (Current)
An Act to protect water supplies and the environment
H.675 194th (Current)
An Act establishing the school supplies for teachers program
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.